시장보고서

상품코드

1906664

눈 알레르기 치료 시장 규모와 예측(2021-2031년) - 세계 및 지역별 점유율, 동향, 성장 기회 분석 보고서 : 치료법별, 적응증별, 유통 채널별, 지역별

Eye Allergy Treatment Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment, Indications, Distribution Channel, and Geography

발행일: 2025년 12월 | 리서치사:

The Insight Partners | 페이지 정보: 영문 211 Pages | 배송안내 : 즉시배송

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

눈 알레르기 치료 시장 규모는 2024년 39억 2,000만 달러에서 2031년까지 59억 7,000만 달러로 성장할 것으로 예측되며, 2025년부터 2031년까지 6.3%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다. 눈 알레르기 유병률 증가, 고령 인구의 급증, 처방약에서 일반의약품으로의 전환은 눈 알레르기 치료 시장 규모 확대에 기여하는 주목할 만한 요인입니다. 또한, 서방형 안구 내 임플란트 및 약물 용출형 콘택트렌즈는 가까운 미래에 새로운 눈 알레르기 치료의 트렌드를 가져올 것으로 예측됩니다.

생물학적 제제 및 면역 조절제는 춘계각 결막염(VKC)이나 아토피성각 결막염(AKC)등의 중독(重篤)증상 치료에 이용됩니다.이러한 치료법은 T세포 응답 조절 이상이나 사이토카인 과잉산생이라고 하는 만성 염증 주요 원인을 표적으로 할 뿐만 아니라, 그것들을 근절 합니다.이것에 의해 장기적으로 녹내장이나 백내장 리스크가 낮은 스테로이드 절약 요법 선택사항을 제공합니다.이 동향은 정밀의료 접근에 의해서 촉진되고 있어 임상시험에서는 난치성 증례에서 최대 80%관해율이 확인된 것에 대해, 기존 국소 치료에서는 50- 60%관해율에 머물고 있습니다.면역 조절제인 국소용 시클로스포린 A(레스트아시스)나 타크로리무스(프로 토픽 점안액)는 칼시뉴린 활성을 저해하는 것으로 T세포 활성화를 억제해, 염증에 관여하는 호산구 수를 감소시킵니다.2024년에 시행 된 28건 무작위화 시험을 대상으로 한 네트워크메타 해석에서는 타크로리무스가 VKC 치료제로서 최고위로 평가되었습니다.

단일 경로를 표적으로 하는 단일클론항체인 생물학적 제제는 안과적 증상을 동반한 알레르기 질환의 치료에서 1차 선택이 되고 있습니다. IL-4/IL-13 억제제인 듀피루맙(듀픽센트)은 임상 3상 시험에서 AKC 환자의 안과적 점수를 75% 개선하는 것으로 나타났으며, 아토피 피부염을 동반한 성인의 가려움증과 광과민증 완화에도 효과가 있는 것으로 나타났습니다. 항IgE 제제인 오말리주맙(졸라이아)은 급성 알레르기성 결막염 환자에서 응급실 방문을 55% 감소시키는 것으로 나타났습니다. 신규 약물인 항-Siglec-8 항체 리렌테리맙도 출시가 임박했으며, VKC의 2상 임상 데이터에서 호산구 침윤을 90% 감소시켜 향후 1차 선택 생물학적 제제로서의 입지를 다졌습니다. 전 세계적으로 알레르기성 안질환이 증가하고 있는 가운데, 앞서 언급한 혁신적인 치료법은 삶의 질을 향상시킬 뿐만 아니라 발작 빈도를 줄이고, 가장 취약한 환자들의 장기적인 관리를 보다 안전하게 할 수 있는 잠재력을 가지고 있어 눈 알레르기 치료 시장에서 중요한 트렌드로 부상할 것으로 예측됩니다. 기대되고 있습니다.

유통 채널별 인사이트

유통 채널에 따라 눈 알레르기 치료 시장은 병원 약국, 온라인 약국, 드럭스토어로 구분됩니다. 2024년 기준 병원 약국 부문이 가장 큰 시장 점유율을 차지했습니다. 의료시설에서 안과 전문의와 알레르기 전문의가 알레르기성 결막염, 봄철 각결막염, 거대유두결막염 등의 질환을 진단하고 치료하는 데 중요한 역할을 하고 있습니다. 예를 들어, 염산 올로파타딘(파타데이), 로테프레드놀에타보네이트(로테맥스) 점안제 등의 의약품은 이들 판매처에서 자주 판매되고 있으며, 병원 환경에서 상세한 평가와 함께 처방전이 발급되는 경우가 많습니다. 이 부문의 발전에는 몇 가지 요인이 있습니다. 첫째, 환경 조건, 도시화, 기후 변화로 인해 악화되는 눈 알레르기 환자 수가 빠르게 증가하고 있다는 점입니다. 도시화, 기후 변화로 인해 악화되고 있는 것을 들 수 있습니다. 이로 인해 환자 수가 증가할 뿐만 아니라, 전문 의료를 찾는 환자들이 병원을 첫 번째 선택지로 삼는 경향이 강해지면서 현장의 의약품 서비스 수요도 증가하고 있습니다. 병원약국의 성장은 임상적 신뢰성, 정책적 지원, 그리고 변화하는 환자 니즈가 복합적으로 작용한 결과이며, 알레르기 질환의 부담이 증가하는 세계에서 효과적인 안구 알레르기 관리의 중요한 경로로 인식되고 있습니다. 이는 눈 알레르기 치료 시장의 성장을 가속하고 있습니다.

눈 알레르기 치료 시장-주요 시장 역학
시장 성장 촉진요인
- 눈알레르기 유병률 증가
- 고령 인구 급증
- 처방약으로부터 시판약에의 이동
시장 성장 억제요인
- 엄격한 규제 승인
- 의약품에 수반하는 부작용
- 제품 리콜 건수 증가
시장 기회
- 의식의 고양과 치료법 진전
- 기업에 의한 전략적 이니셔티브 증가
- 신흥 시장에의 진출
향후 동향
- 지속 방출 형안내 임플란트 및 약제 방출형 콘택트렌즈
- 방부제 프리, 다기능 ' 스마트 ' 점안약
- 중증 증례용 생물학적 제제 및 면역 조절제
성장 촉진요인과 억제요인의 영향

제6장 눈 알레르기 치료 시장-세계 시장 분석

눈 알레르기 치료 시장 매출,2021-2031년
눈 알레르기 치료 시장 예측 분석

제7장 눈 알레르기 치료 시장 분석-치료법별

경구약
알레르기 주사
점안약

제8장 눈 알레르기 치료 시장 분석-적응증별

계절성 및 연중성 알레르기성 결막염
춘계각 결막염
아토피성각 결막염
접촉성 알레르기성 결막염
거대 유두 결막염

제9장 눈 알레르기 치료 시장 분석-판매채널별

병원 약국
온라인 약국
드럭스토어

제10장 눈 알레르기 치료 시장-지역 분석

북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 스페인
- 이탈리아
- 기타 유럽
아시아태평양
- 중국
- 일본
- 인도
- 호주
- 한국
- 아시아태평양 기타 국가
중동 및 아프리카
- 사우디아라비아
- 남아프리카공화국
- 아랍에미리트
- 기타 중동 및 아프리카
남미 및 중남미
- 브라질
- 아르헨티나
- 기타 남미·중앙아메리카 기타 지역

제11장 경쟁 구도

주요 기업별 히트맵 분석
기업 점유율 분석(2024년)

제12장 업계 상황

시장 이니셔티브

제13장 기업 개요

Alcon AG
Bausch+Lomb Corporation
AdvaCare Pharma USA LLC
AbbVie Inc
Sun Pharmaceutical Industries Ltd
Grevis Pharmaceuticals Pvt Ltd.
Santen Pharmaceutical Co., Ltd.
Bayer AG
ZEXUS PHARMA
Lupin Ltd

제14장 부록

LSH 26.01.22

The eye allergy treatment market size is expected to grow from US$ 3.92 billion in 2024 to US$ 5.97 billion by 2031; it is projected to register a CAGR of 6.3% during 2025-2031. The increasing eye allergy prevalence, surging geriatric population, and prescription to over-the-counter transition are noteworthy factors contributing to the expansion of the eye allergy treatment market size. Additionally, the sustained-release ocular implants and drug-eluting contact lenses are projected to bring new eye allergy treatment market trends in the near future.

Biologics and immunomodulators are used for treating severe conditions such as vernal keratoconjunctivitis (VKC) and atopic keratoconjunctivitis (AKC). These therapies not only target but also eliminate the main causes of chronic inflammation, such as T-cell response dysregulation and cytokine overproduction, thus providing steroid-sparing options that carry lower risks of glaucoma and cataracts in the long run. This trend is being facilitated by the precision medicine approach, as shown in clinical trials where refractory cases had remission rates of up to 80%, while traditional topical treatments had rates of 50-60% only. Immunomodulators, such as topical cyclosporine A (Restasis) and tacrolimus (Protopic ophthalmic), are the drugs that inhibit the activity of calcineurin, thereby preventing the activation of T-cells and bringing down the number of eosinophils involved in the inflammation. A network meta-analysis conducted in 2024 involving 28 randomized trials rated tacrolimus as the top drug for VKC.

Biologics, which are monoclonal antibodies that target single pathways, are becoming the treatment of choice for the medical side of allergies with ocular manifestations. Dupilumab (Dupixent), an IL-4/IL-13 inhibitor, has been shown to improve the ocular scores in patients with AKC by 75% in phase 3 clinical trials, and at the same time, it has been relieving itch and light sensitivity in adults with co-existing atopic dermatitis. Omalizumab (Xolair), an anti-IgE agent, has been able to cut emergency visits by 55% in the population of patients suffering from acute allergic conjunctivitis. The new drug lirentelimab, an anti-Siglec-8 antibody, is also on the horizon, having achieved 90% pledged eosinophil infiltration reduction in VKC phase 2 data, thus earning its place as a frontline biologic in the future. As a result of the increasing cases of allergic eye disease worldwide, the aforementioned innovations not only promise to improve quality of life but also to reduce the frequency of flare-ups and to make long-term management safer for the most vulnerable patients, and are expected to emerge as a significant trend in the eye allergy treatment market.

Distribution Channel-Based Insights

Based on distribution channel, the eye allergy treatment market is segmented into the hospital pharmacies, online pharmacy, and drug stores. The hospital pharmacies segment held the largest eye allergy treatment market share in 2024. In the healthcare facilities, these outlets play an important role where ophthalmologists and allergists diagnose and treat conditions such as allergic conjunctivitis, vernal keratoconjunctivitis, and giant papillary conjunctivitis with medicines. Medications like olopatadine hydrochloride (Pataday) and loteprednol etabonate (Lotemax) eye drops, for example, are often sold in these outlets, and they are not infrequently prescribed in-depth evaluations in hospital settings. There are several reasons leading to the development of this segment. The first one is that the rapidly increasing number of eye allergies, aggravated by environmental conditions, urbanization, and climate change, not only attracts more patients but also increases the demand for pharmaceutical services onsite since hospitals are becoming the patients' first choice for specialized care The growth of hospital pharmacies is a reflection of a combination of clinical reliability, policy support, and evolving patient needs, thus, they are recognized as a crucial channel for effective eye allergy management in a world that is increasingly becoming allergy-burdened, thereby fueling the eye allergy treatment market growth.

The World Health Organization and Asthma and Allergy Foundation of America are among the primary and secondary sources referred to while preparing the eye allergy treatment market report.

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Analyst Market Outlook
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
3.3 Assumptions and Limitations

4. Eye Allergy Treatment Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 List of Vendors in the Value Chain

5. Eye Allergy Treatment Market - Key Market Dynamics

5.1 Eye Allergy Treatment Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increasing Eye Allergies Prevalence
- 5.2.2 Surging Geriatric Population
- 5.2.3 Prescription to Over-the-Counter Transition
5.3 Market Restraints
- 5.3.1 Stringent Regulatory Approvals
- 5.3.2 Side Effects Associated with Medications
- 5.3.3 Increasing Number of Product Recalls
5.4 Market Opportunities
- 5.4.1 Heightened Awareness and Treatments
- 5.4.2 Rising Strategic Initiatives by Companies
- 5.4.3 Emerging Market Penetration
5.5 Future Trends
- 5.5.1 Sustained-Release Ocular Implants and Drug-Eluting Contact Lenses
- 5.5.2 Preservative-Free, Multi-Action andldquo;Smartandrdquo; Eye Drops
- 5.5.3 Biologics and Immunomodulators for Severe Cases
5.6 Impact of Drivers and Restraints:

6. Eye Allergy Treatment Market - Global Market Analysis

6.1 Eye Allergy Treatment Market Revenue (US$ Million), 2021-2031
6.2 Eye Allergy Treatment Market Forecast Analysis

7. Eye Allergy Treatment Market Analysis - by Treatment

7.1 Oral Medication
- 7.1.1 Overview
- 7.1.2 Oral Medication: Eye Allergy Treatment Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Allergy Shots
- 7.2.1 Overview
- 7.2.2 Allergy Shots: Eye Allergy Treatment Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Eye Drops
- 7.3.1 Overview
- 7.3.2 Eye Drops: Eye Allergy Treatment Market - Revenue and Forecast to 2031 (US$ Million)

8. Eye Allergy Treatment Market Analysis - by Indications

8.1 Seasonal and Perennial Allergic Conjunctivitis
- 8.1.1 Overview
- 8.1.2 Seasonal and Perennial Allergic Conjunctivitis: Eye Allergy Treatment Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Vernal Keratoconjunctivitis
- 8.2.1 Overview
- 8.2.2 Vernal Keratoconjunctivitis: Eye Allergy Treatment Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Atopic Keratoconjunctivitis
- 8.3.1 Overview
- 8.3.2 Atopic Keratoconjunctivitis: Eye Allergy Treatment Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Contact Allergic Conjunctivitis
- 8.4.1 Overview
- 8.4.2 Contact Allergic Conjunctivitis: Eye Allergy Treatment Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Giant Papillary Conjunctivitis
- 8.5.1 Overview
- 8.5.2 Giant Papillary Conjunctivitis: Eye Allergy Treatment Market - Revenue and Forecast to 2031 (US$ Million)

9. Eye Allergy Treatment Market Analysis - by Distribution Channel

9.1 Hospital Pharmacies
- 9.1.1 Overview
- 9.1.2 Hospital Pharmacies: Eye Allergy Treatment Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Online Pharmacy
- 9.2.1 Overview
- 9.2.2 Online Pharmacy: Eye Allergy Treatment Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Drug Stores
- 9.3.1 Overview
- 9.3.2 Drug Stores: Eye Allergy Treatment Market - Revenue and Forecast to 2031 (US$ Million)

10. Eye Allergy Treatment Market - Geographical Analysis

10.1 North America
- 10.1.1 North America Eye Allergy Treatment Market Overview
- 10.1.2 North America: Eye Allergy Treatment Market - Revenue, 2021-2031 (US$ Million)
  - 10.1.2.1 North America: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Treatment
  - 10.1.2.2 North America: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Indications
  - 10.1.2.3 North America: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Distribution Channel
- 10.1.3 North America: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Country
  - 10.1.3.1 United States: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.3.1.1 United States: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.1.3.1.2 United States: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.1.3.1.3 United States: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.1.3.2 Canada: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.3.2.1 Canada: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.1.3.2.2 Canada: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.1.3.2.3 Canada: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.1.3.3 Mexico: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.3.3.1 Mexico: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.1.3.3.2 Mexico: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.1.3.3.3 Mexico: Eye Allergy Treatment Market Breakdown, by Distribution Channel
10.2 Europe
- 10.2.1 Europe Eye Allergy Treatment Market Overview
- 10.2.2 Europe: Eye Allergy Treatment Market - Revenue, 2021-2031 (US$ Million)
  - 10.2.2.1 Europe: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Treatment
  - 10.2.2.2 Europe: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Indications
  - 10.2.2.3 Europe: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Distribution Channel
- 10.2.3 Europe: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Country
  - 10.2.3.1 United Kingdom: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.1.1 United Kingdom: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.2.3.1.2 United Kingdom: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.2.3.1.3 United Kingdom: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.2.3.2 Germany: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.2.1 Germany: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.2.3.2.2 Germany: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.2.3.2.3 Germany: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.2.3.3 France: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.3.1 France: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.2.3.3.2 France: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.2.3.3.3 France: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.2.3.4 Spain: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.4.1 Spain: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.2.3.4.2 Spain: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.2.3.4.3 Spain: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.2.3.5 Italy: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.5.1 Italy: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.2.3.5.2 Italy: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.2.3.5.3 Italy: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.2.3.6 Rest of Europe: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.2.3.6.1 Rest of Europe: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.2.3.6.2 Rest of Europe: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.2.3.6.3 Rest of Europe: Eye Allergy Treatment Market Breakdown, by Distribution Channel
10.3 Asia Pacific
- 10.3.1 Asia Pacific Eye Allergy Treatment Market Overview
- 10.3.2 Asia Pacific: Eye Allergy Treatment Market - Revenue, 2021-2031 (US$ Million)
  - 10.3.2.1 Asia Pacific: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Treatment
  - 10.3.2.2 Asia Pacific: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Indications
  - 10.3.2.3 Asia Pacific: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Distribution Channel
- 10.3.3 Asia Pacific: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Country
  - 10.3.3.1 China: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.1.1 China: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.3.3.1.2 China: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.3.3.1.3 China: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.3.3.2 Japan: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.2.1 Japan: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.3.3.2.2 Japan: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.3.3.2.3 Japan: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.3.3.3 India: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.3.1 India: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.3.3.3.2 India: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.3.3.3.3 India: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.3.3.4 Australia: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.4.1 Australia: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.3.3.4.2 Australia: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.3.3.4.3 Australia: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.3.3.5 South Korea: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.5.1 South Korea: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.3.3.5.2 South Korea: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.3.3.5.3 South Korea: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.3.3.6 Rest of APAC: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.3.3.6.1 Rest of APAC: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.3.3.6.2 Rest of APAC: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.3.3.6.3 Rest of APAC: Eye Allergy Treatment Market Breakdown, by Distribution Channel
10.4 Middle East and Africa
- 10.4.1 Middle East and Africa Eye Allergy Treatment Market Overview
- 10.4.2 Middle East and Africa: Eye Allergy Treatment Market - Revenue, 2021-2031 (US$ Million)
  - 10.4.2.1 Middle East and Africa: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Treatment
  - 10.4.2.2 Middle East and Africa: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Indications
  - 10.4.2.3 Middle East and Africa: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Distribution Channel
- 10.4.3 Middle East and Africa: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Country
  - 10.4.3.1 Saudi Arabia: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.3.1.1 Saudi Arabia: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.4.3.1.2 Saudi Arabia: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.4.3.1.3 Saudi Arabia: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.4.3.2 South Africa: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.3.2.1 South Africa: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.4.3.2.2 South Africa: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.4.3.2.3 South Africa: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.4.3.3 United Arab Emirates: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.3.3.1 United Arab Emirates: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.4.3.3.2 United Arab Emirates: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.4.3.3.3 United Arab Emirates: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.4.3.4 Rest of Middle East and Africa: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.4.3.4.1 Rest of Middle East and Africa: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.4.3.4.2 Rest of Middle East and Africa: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.4.3.4.3 Rest of Middle East and Africa: Eye Allergy Treatment Market Breakdown, by Distribution Channel
10.5 South and Central America
- 10.5.1 South and Central America Eye Allergy Treatment Market Overview
- 10.5.2 South and Central America: Eye Allergy Treatment Market - Revenue, 2021-2031 (US$ Million)
  - 10.5.2.1 South and Central America: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Treatment
  - 10.5.2.2 South and Central America: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Indications
  - 10.5.2.3 South and Central America: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Distribution Channel
- 10.5.3 South and Central America: Eye Allergy Treatment Market - Revenue and Forecast Analysis - by Country
  - 10.5.3.1 Brazil: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.5.3.1.1 Brazil: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.5.3.1.2 Brazil: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.5.3.1.3 Brazil: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.5.3.2 Argentina: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.5.3.2.1 Argentina: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.5.3.2.2 Argentina: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.5.3.2.3 Argentina: Eye Allergy Treatment Market Breakdown, by Distribution Channel
  - 10.5.3.3 Rest of South and Central America: Eye Allergy Treatment Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.5.3.3.1 Rest of South and Central America: Eye Allergy Treatment Market Breakdown, by Treatment
    - 10.5.3.3.2 Rest of South and Central America: Eye Allergy Treatment Market Breakdown, by Indications
    - 10.5.3.3.3 Rest of South and Central America: Eye Allergy Treatment Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis by Key Players
11.2 Company Market Share Analysis, 2024

12. Industry Landscape

12.1 Overview
12.2 Market Initiative

13. Company Profiles

13.1 Alcon AG
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Bausch + Lomb Corporation
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 AdvaCare Pharma USA LLC
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 AbbVie Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Sun Pharmaceutical Industries Ltd
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Grevis Pharmaceuticals Pvt Ltd.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Santen Pharmaceutical Co., Ltd.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Bayer AG
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 ZEXUS PHARMA
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Lupin Ltd
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners
14.2 List of Abbreviations